Between 2019 and 2023, point-of-care marketing spend grew 171%, reaching over $803 million, according to the Point of Care Marketing Association (POCMA). That growth reflects a fundamental shift in how pharma brands reach physicians. Point-of-care marketing ROI now sits at the center of media allocation decisions for pharma teams, EHR platform leaders, and health system executives. Understanding what drives those returns and what limits them changes how campaigns are built and measured.
The decline of pharma sales rep access is sharper than most media plans account for. In 2008, 80% of healthcare providers were rep-accessible, meaning they would meet with more than 70% of sales representatives who approached them. By 2017, that figure had dropped to 44%, according to BioPharma Dive. Over the same period, pharma spend on HCP digital display and print advertising fell 22%, while point-of-care spend grew at 22% annually per POCMA data.
Point-of-care marketing grew in the opposite direction because it solves the access problem directly. Physicians who are too busy to take a rep meeting still log into their EHR dozens of times per shift. That screen time is the most reliable access point in modern HCP engagement.
What Actually Drives Point-of-Care Marketing ROI?
Point-of-care marketing ROI breaks down into three inputs: reach, relevance, and timing.
Reach is the easiest to quantify. EHR-based delivery tracks impressions at the NPI level, giving pharma teams a verifiable count of qualified prescribers who saw the message.
Relevance separates high-performing campaigns from average ones. A chronic disease message appearing during a routine annual physical carries low relevance. The same message appearing when a physician enters a lab result outside the normal range carries high relevance. Context-triggered delivery targets the clinical signal, not just the login event.
Timing closes the loop. Point-of-care channels reach HCPs during the prescribing moment itself. No outreach channel, email, paid media, or rep visit, matches the timing precision of a message embedded in an active clinical workflow.
Spark powered by Doceree's Patented Triggers™ Technology fires messages based on live clinical context: diagnosis codes, patient data, and specific workflow events. A pharma message tied to a relevant ICD-10 code lands at exactly the right clinical moment, aligning all three ROI drivers simultaneously.
How EHR Platforms Capture Point-of-Care Revenue
For EHR platforms, point-of-care marketing ROI is both an advertiser metric and a platform revenue model. Pharma brands pay for clinical inventory because physician time inside EHR systems keeps growing. That screen time, paired with context-triggered messaging technology, converts workflow moments into revenue.
Spark for EHRs integrates natively into Epic, Cerner, and all major EHR platforms, adding a trigger-based messaging layer without disrupting existing physician workflows. EHR vendors gain a revenue stream from existing screen real estate. Pharma brands gain workflow-native access. Neither comes at the cost of the physician experience.
How Health Systems Measure Point-of-Care Returns
Health systems evaluate point-of-care returns through a different lens. The relevant signals are clinical: formulary adherence, protocol compliance, treatment appropriateness, and downstream patient outcomes.
When HCPs receive contextually relevant information at the prescribing moment, treatment decisions align more closely with clinical evidence and health system goals. Spark for Health Systems delivers personalized messaging across enterprise networks built on patient context and live HCP action, giving health system leaders the ability to tie messaging directly to quality metrics and population health targets.
Frequently Asked Questions
What is point-of-care marketing ROI?
Point-of-care marketing ROI is the return pharma brands and health systems generate from messages delivered to HCPs at the moment of clinical interaction. For pharma teams, it typically measures script lift and engagement rates. For health systems, the return is measured through treatment adherence, formulary compliance, and clinical outcome improvements. Context-triggered EHR delivery consistently outperforms static display placements on both dimensions.
How does context-triggered delivery improve point-of-care marketing ROI?
Context-triggered delivery ties the message to a specific clinical event, such as a relevant diagnosis code or abnormal lab result, rather than a generic login or page view. This raises relevance and drives engagement. A message appearing when the clinical signal is already present faces minimal attention competition inside the workflow and requires no additional persuasion context to land effectively.
What metrics should pharma teams track for point-of-care campaigns?
The most direct ROI metrics are NPI-level delivery confirmation, script lift versus a matched control cohort, engagement rate (click or fulfillment action), and time-to-prescribe. For campaigns that include co-pay or patient support content, copay redemption rate and new-to-brand patient starts also feed into ROI calculations. Attribution is cleaner in EHR-based delivery because the prescribing action happens in the same system.
Can health systems use point-of-care messaging for non-pharma purposes?
Yes. Health systems use point-of-care messaging to reinforce clinical protocols, reduce care variation, surface formulary alternatives, and support quality improvement programs. The same trigger logic that serves pharma campaigns can fire internal health system messages based on patient data and physician workflow events. Spark for Health Systems supports both pharma-sponsored messaging and health system-initiated clinical communication in a single integrated platform.
Ready to see how Spark powered by Doceree delivers point-of-care ROI? Book a demo at info.doceree.com/spark-demo